Skip to main content

Table 5 Costs among ICU patients (n = 15,014) with and without new-onset atrial fibrillation (NOAF)

From: New-onset atrial fibrillation and associated outcomes and resource use among critically ill adults—a multicenter retrospective cohort study

CharacteristicNew-onset atrial fibrillation (n = 1541)No atrial fibrillation (n = 13,473)P value
Total costs, $, mean (SD)50,799 (38,473)41,832 (38,772)< 0.001
Total direct costs, $, mean (SD)37,392 (31,538)30,231 (32,922)< 0.01
Total cost per survivor, $81,12059,710 
Attributable costs, $, mean (SD)
 Food services1046 (1104)937 (1032)0.37
 Health professionals (non-physician or nursing)2859 (2175)2957 (2.250)0.45
 Laboratory2144 (1910)1877 (1823)< 0.01
 Medical imaging1438 (1672)1401 (1573)0.29
 Pharmacy3582 (3288)2893 (3092)< 0.001
 Respiratory therapy3944 (6188)3748 (6229)0.48
 Nursing39,492 (36,493)28,344 (31,302)< 0.001
ICU costs, $, mean (SD)
 Total costs41,303 (37,743)28,298 (41,393)< 0.001
 Direct costs31,874 (30,838)21,323 (21,504)< 0.001
 Indirect costs9239 (8482)7367 (8043)0.08
  1. Abbreviations: IQR interquartile range, NEMS Nine Equivalents of Nursing Manpower Scale, SD standard deviation